0001562180-23-005506.txt : 20230627
0001562180-23-005506.hdr.sgml : 20230627
20230627080748
ACCESSION NUMBER: 0001562180-23-005506
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230626
FILED AS OF DATE: 20230627
DATE AS OF CHANGE: 20230627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Etherington Robert Dee
CENTRAL INDEX KEY: 0001835330
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39834
FILM NUMBER: 231044009
MAIL ADDRESS:
STREET 1: 6550 SOUTH MILLROCK DRIVE
STREET 2: SUITE G50
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clene Inc.
CENTRAL INDEX KEY: 0001822791
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 852828339
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
BUSINESS PHONE: 801-676-9695
MAIL ADDRESS:
STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
FORMER COMPANY:
FORMER CONFORMED NAME: Chelsea Worldwide Inc.
DATE OF NAME CHANGE: 20200827
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0407
4
2023-06-26
false
0001822791
Clene Inc.
CLNN
0001835330
Etherington Robert Dee
6550 SOUTH MILLROCK DRIVE
SUITE G50
SALT LAKE CITY
UT
84121
true
true
false
false
Chief Executive Officer
false
Common Stock
2023-06-26
4
P
false
25000.00
0.81
A
25000.00
I
By Trust
Common Stock
56593.00
D
Common Stock
12717.00
I
By LLC
Etherington Revocable Trust purchased 25,000 shares of common stock of Clene Inc. in multiple transactions on June 26, 2023 at prices ranging from $0.80 to $0.82, inclusive, for a weighted average price of $0.81 per share.
The securities are owned by the Etherington Revocable Trust. Mr. Etherington is the co-trustee of the Etherington Revocable Trust. The shares owned by the Etherington Revocable Trust may be deemed to be beneficially owned by Mr. Etherington.
The securities are owned by RDE RX Ventures LLC. Mr. Etherington is the manager of RDE RX Ventures LLC. The shares owned by RDE RX Ventures LLC may also be deemed to be beneficially owned by Mr. Etherington.
/s/ Jerry Miraglia POA
2023-06-27